Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Manitoba

$25,000.00

Mechanism of omega-6 and omega-3 fatty acid transport across the blood brain barrier

EF 2012-13

Résumé
Fatty acids (FAs) are important to both the developing and mature central nervous system. While the brain can make some fatty acids, there are a number of polyunsaturated fatty acids (PUFAs) including linoleic acid (LA) and alpha linolenic acid (ALA) that must be obtained through the diet. In addition, the brain has a limited ability to make key essential omega-6 and omega-3 PUFAs such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These essential fatty acids are absorbed into the bloodstream and enter the brain through brain microvessel endothelial cells that form the blood-brain barrier (BBB). In addition, how proinflammatory FAs such as arachidonic acid (AA) enter into the brain and alter brain function is unknown. The proposed research will examine how FA transport across the BBB occurs with a focus on the PUFAs which are primarily obtained through the diet and on AA, a known proinflammatory FA. Our hypothesis is that the essential PUFAs, ALA, EPA and DHA undergo transport across the BBB through specific fatty acid transport proteins expressed in the brain microvessel endothelial cells and that AA may dramatically alter not only BBB FA transport but also other membrane transport properties. The objectives of the proposal are to: 1. Determine the mechanisms for transport of omega-6 and omega-3 fatty acids across the BBB., 2. Examine the cellular processing of these FAs in the brain microvasculature., 3. Evaluate the effects of both short-term (i.e. 2-60 min) and long-term (i.e. 24-48 h) exposure of FAs on BBB function. The proposed studies will provide important information concerning the mechanisms involved in PUFA transport and distribution in the brain and the effects of PUFAs on BBB function. Given the evidence concerning the vital importance of PUFA in human brain function, the proposed studies are fundamental to the application of various PUFA in the development of the brain and the treatment of central nervous system related diseases such as Alzheimer's disease , depression, schizophrenia, attention deficit and hyperactivity disorders.
Programme
Discovery Grants Program - Individual
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
418033-2012
Name nom
Hatch, Grant
Department département
Pharmacology and Therapeutics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5405
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Lipids
Research subject fr
Lipides
Partie
1
Nb partie
1
Application title
Mechanism of omega-6 and omega-3 fatty acid transport across the blood brain barrier
Keyword
NSERC
Application summary
Fatty acids (FAs) are important to both the developing and mature central nervous system. While the brain can make some fatty acids, there are a number of polyunsaturated fatty acids (PUFAs) including linoleic acid (LA) and alpha linolenic acid (ALA) that must be obtained through the diet. In addition, the brain has a limited ability to make key essential omega-6 and omega-3 PUFAs such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These essential fatty acids are absorbed into the bloodstream and enter the brain through brain microvessel endothelial cells that form the blood-brain barrier (BBB). In addition, how proinflammatory FAs such as arachidonic acid (AA) enter into the brain and alter brain function is unknown. The proposed research will examine how FA transport across the BBB occurs with a focus on the PUFAs which are primarily obtained through the diet and on AA, a known proinflammatory FA. Our hypothesis is that the essential PUFAs, ALA, EPA and DHA undergo transport across the BBB through specific fatty acid transport proteins expressed in the brain microvessel endothelial cells and that AA may dramatically alter not only BBB FA transport but also other membrane transport properties. The objectives of the proposal are to: 1. Determine the mechanisms for transport of omega-6 and omega-3 fatty acids across the BBB., 2. Examine the cellular processing of these FAs in the brain microvasculature., 3. Evaluate the effects of both short-term (i.e. 2-60 min) and long-term (i.e. 24-48 h) exposure of FAs on BBB function. The proposed studies will provide important information concerning the mechanisms involved in PUFA transport and distribution in the brain and the effects of PUFAs on BBB function. Given the evidence concerning the vital importance of PUFA in human brain function, the proposed studies are fundamental to the application of various PUFA in the development of the brain and the treatment of central nervous system related diseases such as Alzheimer's disease , depression, schizophrenia, attention deficit and hyperactivity disorders.